Figure 17

CMAP analysis results of low- and high-risk phenotypes in TCGA cohort. (A) Chemical structure of anisomycin; (B) Chemical structure of nystatin; (C) Chemical structure of bumetanide; (D) CMap analysis results list.
CMAP analysis results of low- and high-risk phenotypes in TCGA cohort. (A) Chemical structure of anisomycin; (B) Chemical structure of nystatin; (C) Chemical structure of bumetanide; (D) CMap analysis results list.